Aveanna Healthcare Holdings Inc
$ 9.49
1.93%
07 Aug - close price
- Market Cap 2,064,170,000 USD
- Current Price $ 9.49
- High / Low $ 9.52 / 9.28
- Stock P/E 7.84
- Book Value 1.11
- EPS 1.21
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.10 %
- ROE 0.37 %
- 52 Week High 10.32
- 52 Week Low 5.93
About
Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.
Analyst Target Price
$10.45
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-19 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-03-13 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-09 | 2023-08-10 |
| Reported EPS | 0.18 | 0.17 | 0.15 | 0.16 | 0.1 | 0.05 | 0.02 | 0.01 | -0.03 | -0.02 | -0.03 | -0.02 |
| Estimated EPS | 0.13 | 0.1319 | 0.13 | 0.01 | -0.0038 | -0.0005 | -0.01 | -0.02 | -0.05 | -0.02 | -0.02 | -0.04 |
| Surprise | 0.05 | 0.0381 | 0.02 | 0.15 | 0.1038 | 0.0505 | 0.03 | 0.03 | 0.02 | 0 | -0.01 | 0.02 |
| Surprise Percentage | 38.4615% | 28.8855% | 15.3846% | 1500% | 2731.5789% | 10100% | 300% | 150% | 40% | 0% | -50% | 50% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.16 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AVAH
2026-08-08 13:09:42
Aveanna Healthcare Holdings Inc. announced that Dr. Erica Schwartz, a Class III director, resigned from the company's Board of Directors, effective August 5, 2026. Her resignation is due to her nomination and subsequent confirmation as the Director of the United States Centers of Disease Control and Prevention. Dr. Schwartz's departure was not a result of any disagreement with the company's operations, policies, or practices.
2026-08-07 23:40:33
Dr. Erica Schwartz, the new director of the Centers for Disease Control and Prevention (CDC), has resigned from her position on the board of Aveanna Healthcare Holdings (Nasdaq: AVAH). This resignation is a direct result of her nomination and confirmation as CDC director, as detailed in her ethics agreement and financial disclosures. Schwartz also stepped down from her role as president of insurance solutions at United Healthcare.
2026-08-07 23:40:33
Dr. Erica Schwartz has resigned from her position as a Class III director on Aveanna Healthcare's board, effective immediately. This resignation follows her nomination and confirmation as the director of the U.S. Centers for Disease Control and Prevention (CDC). Schwartz previously served as an independent director and chaired the Clinical Quality Committee for Aveanna Healthcare.
2026-08-06 23:40:33
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a "Moderate Buy" consensus recommendation from brokerages, with an average 12-month price target of $10.78, surpassing its opening price of $9.33. The company exceeded quarterly earnings expectations, reporting $0.18 EPS against a $0.13 consensus and revenue of $647.91 million, a 15.9% year-over-year increase. Despite significant insider sales totaling over 31.3 million shares, institutional investors maintain a substantial 87.96% ownership of the stock.
2026-08-03 21:09:19
A recent SEC filing (SCHEDULE 13G/A) for Aveanna Healthcare Holdings Inc. (AVAH) reveals that entities affiliated with J.H. Whitney, including PSA Healthcare Investment Holding LLC and J.H. Whitney VII, L.P., report significant beneficial ownership of Aveanna's common stock. Due to a Stockholders Agreement, the J.H. Whitney parties and funds advised by Bain Capital Investors, LLC may collectively be deemed to beneficially own over 50% of Aveanna's common stock, specifically 110,666,770 shares or 50.82%. This agreement coordinates director voting and share transfers among the involved parties, although individual reporting entities disclaim beneficial ownership of shares held by others within the group.
2026-07-31 20:11:25
This article highlights bullish sentiments from analysts on two healthcare companies: Labcorp Holdings (LH) and Cytokinetics (CYTK). William Blair analyst Jared Haase maintained a Buy rating on Labcorp Holdings, while H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Cytokinetics with a set price target. Both companies have a "Strong Buy" consensus rating from analysts, with predicted upsides from their current stock levels.
